Dr. Gas Pharmaceuticals Private Limited

Founded in 2013 and headquartered in Uttar Pradesh, India.

2013 | Gonda, Uttar Pradesh (India) | Inactive
Last Updated: March 30, 2024

Dr. Gas Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 8 Months
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth %
  • Profit Growth 45.45%
  • Ebitda 45.45%
  • Net Worth
  • Total Assets -2.37%

About Dr. Gas Pharmaceuticals

Dr. Gas Pharmaceuticals Private Limited (DGPPL) is Strike Off company established on 04 Jun 2013 with its office registered at Gonda, Uttar Pradesh, India and has been running since 11 Year, 8 Months with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 30 Mar 2024.

Company Details

  • Location

    Gonda, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24233UP2013PTC057420

  • Company No.

    057420

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 Jun 2013

  • Date of AGM

    29 Sep 2017

  • Date of Balance Sheet

    31 Mar 2017

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Chemicals
Pharmaceuticals

Who are the key members and board of directors at Dr. Gas Pharmaceuticals?

Board Members (2)

Name Designation Appointment Date Status
Harendra Singh Country flag representing In Director 04-Jun-2013 Current
Sangeet Singh Country flag representing In Director 04-Jun-2013 Current

Financial Performance of Dr. Gas Pharmaceuticals.

Dr. Gas Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 45.45% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-2.37%
Profit or Loss
45.45%
Net Worth
EBITDA
45.45%

What is the Ownership and Shareholding Structure of Dr. Gas Pharmaceuticals?

In 2017, Dr. Gas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Dr. Gas Pharmaceuticals?

Unlock and access historical data on people associated with Dr. Gas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dr. Gas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Gas Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dr. Gas Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Dr. Gas Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.

    29 Sep 2017

  • Balance Sheet

    Dr. Gas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Kanpur.

    31 Mar 2017

  • Director Appointment

    Harendra Kumar Singh was appointed as a Director was appointed as a Director on 04 Jun 2013 & has been associated with this company since 11 years 8 months .

    04 Jun 2013

  • Director Appointment

    Sangeet Shivbheekh Singh was appointed as a Director was appointed as a Director on 04 Jun 2013 & has been associated with this company since 11 years 8 months .

    04 Jun 2013

  • Company Incorporation

    Dr. Gas Pharmaceuticals Private Limited was registered on 04 Jun 2013 with Roc Kanpur & aged 11 years 8 months as per MCA records.

    04 Jun 2013

Frequently asked questions

  • Dr. Gas Pharmaceuticals Private Limited was incorporated on 04 Jun 2013.

  • The authorized share capital of Dr. Gas Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Dr. Gas Pharmaceuticals Private Limited.

    • Harendra Kumar Singh
    • Sangeet Shivbheekh Singh
  • As per Ministry of Corporate Affairs (Mca), the registered address of Dr. Gas Pharmaceuticals Private Limited is 462/358 I T I Road, Civil Lines, Gonda, Uttar Pradesh, India, 271001.

  • The corporate identification number (CIN) of Dr. Gas Pharmaceuticals Private Limited is U24233UP2013PTC057420 and the company number is 057420 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Dr. Gas Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2017.